(Q33348817)

26 July 2017

title

Argatroban dosing in patients with heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

based on heuristic

inferred from title

author name string

Catherine N Verme-Gibboney

series ordinal

1

1 reference

26 July 2017

Marcie J Hursting

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Annals of Pharmacotherapy

26 July 2017

published in

1 reference

26 July 2017

volume

37

1 reference

26 July 2017

issue

7-8

1 reference

26 July 2017

page(s)

970-975

1 reference

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

26 July 2017

cites work

1 reference

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

21 January 2018

1 reference

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects

21 January 2018

1 reference

Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia

21 January 2018

1 reference

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C443

1 reference

26 July 2017

1 reference